DISPATCHESM any key epidemiologic and serologic characteristics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remain unknown. Few seroprevalence studies have been conducted in Africa to better understand the landscape of humoral immunity. In Sudan, 32,846 confirmed cases of coronavirus disease (COVID-19) were recorded during March 13, 2020-April 10, 2021; of those, 72% were registered in the state of Khartoum alone (1). A study of a convenience sample of >1,000 participants from 22 neighborhoods of the city of Khartoum in March-July 2020 found that 35% of participants were positive by real time RT-PCR for SARS-CoV-2, and 18% had SARS-CoV-2 antibodies (2). Similar discrepancies between clinical confirmed cases and infection rates assessed by serology or PCR testing independent of symptoms have been described elsewhere in Africa (3-5).The National Health Review Ethics Committee (no. 3-1-21), Médecins Sans Frontières Ethics Review Board (ID 2089c), and Khartoum State Ministry of Health approved this study. Before field data collection began, we visited the leader of the resistance committee for each block to obtain verbal consent. For the mortality survey, we obtained verbal consent from the head of the household. For the seroprevalence survey, we obtained written informed consent from adults and, for participants <18 years of age, first written informed consent from parents or legal guardians and second, oral assent from the participants themselves. The StudySudan's capital, Khartoum, is a tripartite metropolis comprising Khartoum, Bahri, and Omdurman; it has >8 million inhabitants (6). We chose Omdurman, the largest of the 3 cities, as the study site for 2 surveys conducted in March-July 2020 (Appendix, https:// wwwnc.cdc.gov/EID/article/28/5/21-1951-App1. pdf). One, a retrospective mortality survey, was conducted using a 2-stage cluster sampling methodology based on random geopoints with 2 recall periods, the prepandemic (January 1, 2019-February 29, 2020) and the pandemic period (March 1, 2020-date of survey); an adult representative of the household answered a standardized questionnaire. The second was a nested SARS-CoV-2 antibody prevalence survey; all the members of a subset of the household, regardless of age, were invited to participate in the seroprevalence study.Capillary blood was collected on dried blood spot cards and directly tested with the STANDARD
Background Even after adjusting for the expected lower severity due to the younger age of the population, relatively low SARS–CoV–2 incidence and mortality rates have been reported throughout Africa. For investigating whether this is truly the case, we conducted a survey to estimate the COVID–19 related mortality and cumulative incidence of SARS–CoV–2 infections in Omdurman the most populated city of the tripartite metropolis Khartoum in Sudan. Methods A retrospective, cross–sectional, mortality and seroprevalence survey was conducted in Omdurman, Sudan, from March 1, until April 10 2021. A two–stage cluster sampling method was used to investigate the death rate for the pre–pandemic (January 1, 2019–February 29, 2020) and pandemic (March 1, 2020 – day of the survey) period using questionnaires. The seroprevalence survey was performed in a subset of households and all consenting members were tested with a rapid serological test (SD–Biosensor) and a subgroup additionally with ELISA (EUROIMMUN). Fisher′s exact test was used to assess differences between the pre–and pandemic periods and a random effect and Bayesian latent class model to adjust for test performance. Findings Data from 27315 people (3716 households) for the entire recall period showed a 67% (95% CI 32–110) increase in death rate between the pre–pandemic (0.12 deaths/10000 people/day [95% CI 0.10–0.14]) and pandemic (0.20 [0.16–0.23]) periods. Notably, a 74% (30–133) increase in death was observed among people aged ≥50 years. The adjusted seroprevalence of SARS–CoV–2 was 54.6% (95% CI 51.4–57.8). The seroprevalence was significantly associated with age, increasing up to 80.7% (71.7–89.7) for the oldest age group (≥50 years). Interpretation Our results showed a significant elevated mortality for the pandemic period with a considerable excess mortality in Omdurman, Sudan. The overall high seroprevalence indicated a different age pattern compared to other countries, with a significant increase by age. Funding Medécins Sans Frontières
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.